Nigeria Records 54 New Cases of Mpox/Monkeypox

The Nigeria Centre for Disease Control and Prevention (NCDC) has reported 54 new suspected Mpox cases in Nigeria for Week 39 of 2024, down from 75 cases the previous week (38).

Mpox, previously known as Monkeypox, is a viral disease transmitted by contact with infected persons and animals, contaminated objects, and respiratory fluids. It causes swollen lymph nodes, rash or blisters, fever, headache, and joint or muscle pain. The World Health Organization renamed monkeypox to “mpox” in 2022 to reduce the stigmatisation and discrimination associated with the original name.

Mpox Incidence in Nigeria So Far

The NCDC revealed that confirmed cases increased by six from three in week 38. As of Week 39, Nigeria had 84 confirmed and 1,237 suspected cases in 2024. No deaths were recorded among confirmed cases. The NCDC also mentioned that 25 states and the FCT documented confirmed cases across 57 local government areas, with Plateau, Delta, FCT, Katsina, and Imo states reporting new cases.

Since the outbreak began in September 2017, 5,054 reports of suspected Mpox cases in Nigeria and 1,170 confirmed cases have been received. The male population, mainly between 21 and 45 years old, accounts for 68% of confirmed cases.

The National Mpox Emergency Operations Centre is leading the response, working with various sectors to curtail the spread. The NCDC stresses the need for preventive measures, such as avoiding close contact with symptomatic individuals, maintaining good hand hygiene, and using protective gear when caring for suspected cases.

Healthcare workers are encouraged to remain vigilant, especially in affected areas, and isolate suspected cases promptly. The NCDC is actively engaged in public education, encouraging citizens to report symptoms early and adhere to isolation guidelines if diagnosed with Mpox.

Citizens are encouraged to contact the NCDC’s toll-free number (6232) for more information or to report suspected cases.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *